Dr. Sznol on Unanswered Questions With Immunotherapy in RCC OncLive 1:29 5 years ago 139 Скачать Далее
Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal Cancer OncLive 0:50 5 years ago 102 Скачать Далее
Dr. Sznol on Patient Selection for Combination Therapy in mRCC OncLive 1:25 5 years ago 93 Скачать Далее
Unanswered questions in the management of clear cell RCC VJOncology 0:53 2 years ago 766 Скачать Далее
Dr. Sznol on Managing Patients Beyond Initial Treatment in Melanoma OncLive 1:08 4 years ago 145 Скачать Далее
Dr. Sznol on Immunotherapy Combinations for the Treatment of Melanoma Targeted Oncology 1:17 9 years ago 100 Скачать Далее
Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma OncLive 1:22 4 years ago 285 Скачать Далее
Dr. Sznol Discusses the Importance of Clinical Trials in RCC OncLive 0:58 6 years ago 27 Скачать Далее
Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve? European Association of Urology 5:23 3 years ago 520 Скачать Далее
Panel | Dr.Lillian Siu, Dr.Mario Sznol, Dr.Philippe Bedard, Dr.Anna Spreafico & Dr.Derek Clouthier Princess Margaret Cancer Centre 25:37 7 years ago 362 Скачать Далее
Dr. Jonasch on Single-Agent Pembrolizumab in Non-Clear Cell RCC OncLive 1:14 5 years ago 163 Скачать Далее
Dr. Powles on Monitoring Immunotherapy Effects in Patients with RCC OncLive 1:52 5 years ago 292 Скачать Далее
